Welcome to our dedicated page for Perrigo news (Ticker: PRGO), a resource for investors and traders seeking the latest updates and insights on Perrigo stock.
Perrigo Company plc reports recurring developments as a pure-play consumer health company focused on over-the-counter self-care products, store-brand private label offerings, and branded health and wellness products primarily in North America and Europe. Company updates cover operating results from continuing operations, category performance, dividends, investor presentations, and portfolio actions under its Three-S plan to stabilize, streamline, and strengthen the business.
News also addresses Perrigo's product-category reporting and brand momentum across Self Care and Specialty Care, including names such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. Recent corporate developments include the completed divestiture of the Dermacosmetics business and the use of portfolio proceeds for balance-sheet debt reduction.
Perrigo Company plc (NYSE: PRGO) announced a public offering of senior notes by its wholly-owned finance subsidiary, Perrigo Finance Unlimited Company. The offering will fund the redemption of existing senior notes due in 2021, with any remaining proceeds allocated for general corporate purposes. The offering is dependent on market conditions, with BofA Securities, J.P. Morgan, and Wells Fargo Securities serving as joint book-running managers. The company emphasizes that this press release does not constitute an offer to sell securities.